The International Trade Commission delays its ruling on Align Technology's complaint against ClearCorrect until early April.
Align Technology (NSDQ:ALGN) said the International Trade Commission put off the target date for completing its review of a May 2013 decision that ClearCorrect infringed patents for Align's Invisalign teeth-straightening technology.
Biolase steadies itself against a proxy war filed by activist majority shareholder Oracle Partners over alleged manipulation of the board of directors.
Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.
California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."
Align Technology credits a 25% uptick in sales of its Invisalign clear aligner for Q4 and full-year earnings that beat Wall Street's expectations.
California's Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street's expectations.
OrthoAccel raised $5 million through an equity sale, to support its AcceleDent.OrthoAccel Technologies says it raised $5 million in an equity offering to back its AcceleDent sonic orthodontic device.
OrthoAccel Technologies said it brought in $5 million in an equity offering.
The Houston-based company makes the AccelaDent device, which is designed to accelerate tooth movement using sonic technology.
The $5 million came from existing backers Healthpoint Capital and S3 Ventures, along with standing stockholders, according to a press release.
Henry Schein acquires 5 dental software, lab and distribution business from Belgium's Arseus for an undisclosed amount.
Healthcare giant Henry Schein (NSDQ:HSIC) agreed to pay an undisclosed amount to acquire 5 dental businesses from Belgium-based Arseus, the companies announced this week.
Align Technology, its CEO and its CFO managed to dodge a federal class action lawsuit accusing them of reaping millions through insider trading while misstating the dental devices maker's financial position.